Graves' Disease Drug Trial

A new drug is being assessed at UK hospital sites for the treatment for Graves’ disease. The trial is funded by Apitope International NV and the European Commission through a Framework 7 grant and has been approved by the Central Research Ethics Committee and the Medicines and Healthcare Products Regulatory Agency (MHRA).
Source: The British Thyroid Foundation - Category: Endocrinology Tags: Featured Get Involved Source Type: news